Prescribed for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, Xeljanz and Xeljanz XR have been linked to several different injuries including blood clots, pulmonary embolisms, liver damage and cancer.
Recent Xeljanz lawsuits have alleged that Pfizer Inc., the manufacturer of Xeljanz / Xeljanz XR, failed to warn the public of significant side effects that have caused injury to many individuals.
SimplyConvert’s proprietary Instant Case Evaluation Platform can help your team seek justice for people who took the drug and suffered personal injuries.
We partner with the most qualified lawyers in every mass tort to formulate the criteria for qualifying clients. Once we program our AI-powered chatbot with the litigation-specific criteria, it is ready to chat with website visitors and qualify potentially viable claims for the litigation.
Click the button at the end of this post to download SimplyConvert's criteria chatflow for the Xeljanz litigation.
Firms on the SimplyConvert platform can immediately begin case intake for the litigation. (If your team wishes to modify the criteria, we are happy to discuss how we can revise it to work for your practice.) As will all of our Instant Case Evaluators, no litigation-specific training is required.
From the first conversation to a signed contract, SimplyConvert's automation tools put every step of the client intake process on autopilot. If you’re not already using the SimplyConvert platform, get started today and get back to focusing on your clients.